Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122956253 | 12295625 | 3 | F | 20150902 | 20160720 | 20160422 | 20160912 | PER | US-JNJFOC-20160417123 | JANSSEN | 61.60 | YR | A | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122956253 | 12295625 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
122956253 | 12295625 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
122956253 | 12295625 | 3 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 202439 | 20 | MG | TABLET | |||||
122956253 | 12295625 | 4 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | 0 | 75 | MG | UNSPECIFIED | QD | ||||||
122956253 | 12295625 | 5 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | 0 | 75 | MG | UNSPECIFIED | QD | ||||||
122956253 | 12295625 | 6 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
122956253 | 12295625 | 7 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
122956253 | 12295625 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
122956253 | 12295625 | 9 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
122956253 | 12295625 | 10 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
122956253 | 12295625 | 11 | C | AMIODARONE | AMIODARONE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122956253 | 12295625 | 1 | Thrombosis prophylaxis |
122956253 | 12295625 | 2 | Cerebrovascular accident prophylaxis |
122956253 | 12295625 | 3 | Atrial fibrillation |
122956253 | 12295625 | 4 | Coronary artery disease |
122956253 | 12295625 | 5 | Atrial fibrillation |
122956253 | 12295625 | 6 | Product used for unknown indication |
122956253 | 12295625 | 7 | Product used for unknown indication |
122956253 | 12295625 | 8 | Product used for unknown indication |
122956253 | 12295625 | 9 | Product used for unknown indication |
122956253 | 12295625 | 10 | Product used for unknown indication |
122956253 | 12295625 | 11 | Atrial fibrillation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122956253 | 12295625 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122956253 | 12295625 | Epistaxis | |
122956253 | 12295625 | Gastrointestinal haemorrhage | |
122956253 | 12295625 | Pericardial haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122956253 | 12295625 | 1 | 20150505 | 20150902 | 0 | |
122956253 | 12295625 | 2 | 20150505 | 20150902 | 0 | |
122956253 | 12295625 | 3 | 20150505 | 20150902 | 0 | |
122956253 | 12295625 | 4 | 201509 | 0 | ||
122956253 | 12295625 | 5 | 201509 | 0 |